Institutional & Family Asset Management, LLC Viking Therapeutics, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 08, 2024	BUY	$17.4 - $94.5 $243 - $1,323	14 New	14 $1,000
Q2 2023 Aug 09, 2023	BUY	$14.84 - $24.79 $1,484 - $2,479	100 New	100 $1,000

Others Institutions Holding VKTX

# of Institutions

426

Shares Held

63.1M

Call Options Held

7.39M

Put Options Held

5.13M

Black Rock Inc. New York, NY

8.27M
Shares

$418 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

7.79M
Shares

$393 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

3.59M
Shares

$181 Million
3.55% of portfolio
State Street Corp Boston, MA

3.33M
Shares

$168 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

2.33M
Shares

$117 Million
0.02% of portfolio

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.87B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account